Fundraising Fox
Leniobio
Düsseldorf, DE · Founded 2016 · 48 employees on LinkedIn · 1 known investors
Find your way into Leniobio
Sign up to see every warm intro you have to Leniobio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Leniobio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LenioBio develops ALiCE, a cell-free protein expression platform that accelerates the discovery, development, and manufacturing of proteins and biologics for pharmaceutical and vaccine manufacturers. The platform addresses production bottlenecks in drug and vaccine development by enabling faster, scalable biomanufacturing beyond traditional cell-based approaches.
Founders & leadership
Leniobio was founded in 2016 by Remberto Martis.
Investors · 1
Frequently asked questions
- What does Leniobio do?
- LenioBio develops ALiCE, a cell-free protein expression platform that accelerates the discovery, development, and manufacturing of proteins and biologics for pharmaceutical and vaccine manufacturers. The platform addresses production bottlenecks in drug and vaccine development by enabling faster, scalable biomanufacturing beyond traditional cell-based approaches.
- Who founded Leniobio?
- Leniobio was founded by Remberto Martis in 2016.
- Who are Leniobio's investors?
- Leniobio's investors include Bridford Investments (Bridford Group).
- Where is Leniobio headquartered?
- Leniobio is headquartered in Düsseldorf, DE.